(Q36736169)

16 August 2017

1 reference

title

Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management (English)

1 reference

16 August 2017

cardiovascular disease

1 reference

1 reference

1 reference

1

G Y H Lip

1 reference

16 August 2017

A H Barnett

2

1 reference

16 August 2017

A Bradbury

3

1 reference

16 August 2017

F P Cappuccio

4

1 reference

16 August 2017

P S Gill

5

1 reference

16 August 2017

E Hughes

6

1 reference

16 August 2017

C Imray

7

1 reference

16 August 2017

K Jolly

8

1 reference

16 August 2017

K Patel

9

1 reference

16 August 2017

1 March 2007

1 reference

Journal of Human Hypertension

16 August 2017

1 reference

16 August 2017

21

1 reference

16 August 2017

3

1 reference

16 August 2017

183-211

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002126

16 August 2017

0 references

cites work

Glossary of terms relating to ethnicity and race: for reflection and debate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Describing race, ethnicity, and culture in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnicity as a variable in epidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnic monitoring and equity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Declining case fatality rates for acute myocardial infarction in South Asian and white patients in the past 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Are racial and ethnic minorities less willing to participate in health research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Potential impact of a change in the diagnostic criteria for diabetes mellitus on the prevalence of abnormal glucose tolerance in a local community at risk of diabetes: impact of new diagnostic criteria for diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Evaluating national guidelines for prevention of cardiovascular disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The applicability of the Framingham coronary heart disease prediction function to black and minority ethnic groups in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Individual behavioural counselling for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Pharmacotherapy for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Nortriptyline for smoking cessation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevalence, detection, management, and control of hypertension in Ashanti, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Hypertension and renal failure in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Case-control study of stroke and the quality of hypertension control in north west England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Systematic review: antihypertensive drug therapy in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Lessons on the interaction of race and antihypertensive drugs from the VA cooperative study group on antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Hypertension and ethnic group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St James Survey, Trinidad

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

High-density lipoprotein cholesterol and angiographic coronary artery disease in black patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Serum lipids of Indian physicians living in the U.S. compared to U.S.-born physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Serum lipoprotein profile in children from a biracial community: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Serum lipoprotein concentrations in relation to ethnic composition and urbanization in men and women of Trinidad, West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Elevated lipoprotein(a) levels in South Asians in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prescribing of lipid lowering drugs to South Asian patients: ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Sex and racial/ethnic disparities in outcomes after acute myocardial infarction: a cohort study among members of a large integrated health care delivery system in northern California

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Bangladeshi patients present with non-classic features of acute myocardial infarction and are treated less aggressively in east London, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Audit of primary care angina management in Sandwell, England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Do Indo-Asians have smaller coronary arteries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnicity and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Intermittent claudication. A risk profile from The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The prevalence of macrovascular disease and lipid abnormalities amongst diabetic patients in Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Epidemiology of intermittent claudication in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Race as a risk factor in the severity of infragenicular occlusive disease: study of an urban hospital patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Black-white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Impact of race on the treatment for peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Diabetes mellitus is the major risk factor for African Americans who undergo peripheral bypass graft operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Explaining racial variation in lower extremity amputation: a 5-year retrospective claims data and medical record review at an urban teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of African Caribbeans and Europeans in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

The association between cigarette smoking and abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Screening for abdominal aortic aneurysms during a basic medical checkup in residents of a Japanese rural community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Aneurysms of the abdominal aorta. Incidence in blacks and whites in North Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Results of elective abdominal aortic aneurysm repair in the 1990s: A population-based analysis of 2335 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Transient ischemic attacks in the community: occurrence and clinical characteristics. A population survey in the area of Florence, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Incidence trends of ischemic stroke and transient ischemic attacks in a well-defined French population from 1985 through 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke (EROS) Collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Prevalence of atherothrombotic brain infarction, coronary artery disease and peripheral arterial disease in elderly blacks, Hispanics and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Preventable risk factors for coronary heart disease and stroke amongst ethnic groups in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Ethnicity and peripheral arterial disease: the San Diego Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Retrospective study of influence of deprivation on uptake of cardiac rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Comparison of outcome of cardiac rehabilitation in black women and white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Cardiac rehabilitation: the needs of South Asian cardiac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by i

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Commentary: Epidemiological transition, migration, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Blood pressure levels and hypertension status among ethnic groups in England

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The prevalence of hypertension in seven populations of west African origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Improved hypertension management and control: results from the health survey for England 1998

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The seventh myth of lipoprotein(a): where and how is it assembled?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Effect of race on the presentation and management of patients with acute chest pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Procedural success and complications following percutaneous coronary interventions among Asians and Pacific Islanders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The demographics of claudication and the aging of the American population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Peripheral vascular disease in non-insulin-dependent diabetes mellitus in south India

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Pattern of occlusive peripheral vascular disease in India. (clinicopathological study of 79 cases)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The pattern of non-diabetic peripheral vascular disease in South India

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Peripheral arterial disease in African Americans: clinical characteristics, leg symptoms, and lower extremity functioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Racial differences in primary and repeat lower extremity amputation: results from a multihospital study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Ethnicity and peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Abdominal aneurysms in a black population: clinicopathological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Epidemiology of abdominal aortic aneurysms in the Asian community

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Racial distribution of aneurysms in Zimbabwe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularization in older African-Americans, Asians, Hispanics, whites, men, and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Cardiac rehabilitation in the United Kingdom. How complete is the provision?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Cardiac rehabilitation in Scotland: is current provision satisfactory?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Project Dil: a co-ordinated Primary Care and Community Health Promotion Programme for reducing risk factors of coronary heart disease amongst the South Asian community of Leicester--experiences and evaluation of the project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Advice to reduce dietary salt for prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Reduced or modified dietary fat for prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002126

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1002126

1 reference

16 August 2017

1 reference